Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain
Go back to Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain| (NASDAQ: ALZN) | Delayed: 1.88 -0.01 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.89 | 52 Week High | $ | |||
| Open | $1.89 | 52 Week Low | $ | |||
| Day High | $1.89 | P/E | N/A | |||
| Day Low | $1.87 | EPS | $ | |||
| Volume | 12,971 | |||||
